Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy

Introduction Nephrotoxic medication (NTM) is one of the common causes of acute kidney injury (AKI) in critically ill infants. Current knowledge about the long-term effects of NTM exposure and associated AKI during the neonatal period and early infancy is limited. Hence, we aimed to explore the risk...

Full description

Saved in:
Bibliographic Details
Main Authors: Priyanka Ameta, Christine Stoops, David J. Askenazi
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2023.2218486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187113662775296
author Priyanka Ameta
Christine Stoops
David J. Askenazi
author_facet Priyanka Ameta
Christine Stoops
David J. Askenazi
author_sort Priyanka Ameta
collection DOAJ
description Introduction Nephrotoxic medication (NTM) is one of the common causes of acute kidney injury (AKI) in critically ill infants. Current knowledge about the long-term effects of NTM exposure and associated AKI during the neonatal period and early infancy is limited. Hence, we aimed to explore the risk of chronic kidney disease (CKD) after NTM-AKI in this age group.Methods We performed a cross-sectional study including children 2–7 years of age, who had a history of high NTM exposure during NICU hospitalization. Cases and controls were defined as children who developed AKI and who did not develop AKI after NTM exposure, respectively. The primary outcome of interest was to explore the prevalence of composite CKD. In addition, we explored differences in urinary biomarker kidney injury molecule-1 (KIM-1) between the groups.Results We enrolled 48 children, 18 cases and 30 controls in which 25/48 (52%) had at least one finding of CKD. The composite CKD outcome tended to be higher in cases vs controls (61.1% vs. 46.6%, odds ratio = 1.79 (95% confidence interval 0.54-5.8)); however, this was not statistically significant. Median urinary KIM-1 value trended higher in controls, 0.367(0.23-0.59) vs. 0.20 (IQR 0.11-0.47), which was not statistically significant.Conclusion In this study, 52% of children exposed to NTM had at least one marker of CKD at a median age of 5 years. Multicenter, large prospective studies are needed to improve our understanding of the natural course of NTM-AKI and to determine risk factors and strategies to reduce CKD in this high-risk population.
format Article
id doaj-art-c4b7670c993a4e4493e2d172ee765daa
institution OA Journals
issn 0886-022X
1525-6049
language English
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-c4b7670c993a4e4493e2d172ee765daa2025-08-20T02:16:10ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492023-12-0145110.1080/0886022X.2023.2218486Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancyPriyanka Ameta0Christine Stoops1David J. Askenazi2Pediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USANeonatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USAPediatric Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USAIntroduction Nephrotoxic medication (NTM) is one of the common causes of acute kidney injury (AKI) in critically ill infants. Current knowledge about the long-term effects of NTM exposure and associated AKI during the neonatal period and early infancy is limited. Hence, we aimed to explore the risk of chronic kidney disease (CKD) after NTM-AKI in this age group.Methods We performed a cross-sectional study including children 2–7 years of age, who had a history of high NTM exposure during NICU hospitalization. Cases and controls were defined as children who developed AKI and who did not develop AKI after NTM exposure, respectively. The primary outcome of interest was to explore the prevalence of composite CKD. In addition, we explored differences in urinary biomarker kidney injury molecule-1 (KIM-1) between the groups.Results We enrolled 48 children, 18 cases and 30 controls in which 25/48 (52%) had at least one finding of CKD. The composite CKD outcome tended to be higher in cases vs controls (61.1% vs. 46.6%, odds ratio = 1.79 (95% confidence interval 0.54-5.8)); however, this was not statistically significant. Median urinary KIM-1 value trended higher in controls, 0.367(0.23-0.59) vs. 0.20 (IQR 0.11-0.47), which was not statistically significant.Conclusion In this study, 52% of children exposed to NTM had at least one marker of CKD at a median age of 5 years. Multicenter, large prospective studies are needed to improve our understanding of the natural course of NTM-AKI and to determine risk factors and strategies to reduce CKD in this high-risk population.https://www.tandfonline.com/doi/10.1080/0886022X.2023.2218486Nephrotoxic medicationacute kidney injurychronic kidney disease
spellingShingle Priyanka Ameta
Christine Stoops
David J. Askenazi
Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
Renal Failure
Nephrotoxic medication
acute kidney injury
chronic kidney disease
title Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
title_full Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
title_fullStr Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
title_full_unstemmed Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
title_short Risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
title_sort risk of chronic kidney disease in children who developed acute kidney injury secondary to nephrotoxic medication exposure in infancy
topic Nephrotoxic medication
acute kidney injury
chronic kidney disease
url https://www.tandfonline.com/doi/10.1080/0886022X.2023.2218486
work_keys_str_mv AT priyankaameta riskofchronickidneydiseaseinchildrenwhodevelopedacutekidneyinjurysecondarytonephrotoxicmedicationexposureininfancy
AT christinestoops riskofchronickidneydiseaseinchildrenwhodevelopedacutekidneyinjurysecondarytonephrotoxicmedicationexposureininfancy
AT davidjaskenazi riskofchronickidneydiseaseinchildrenwhodevelopedacutekidneyinjurysecondarytonephrotoxicmedicationexposureininfancy